MAM
GMAB icon

Marquette Asset Management’s Genmab GMAB Stock Holding History

Marquette Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-124
Closed -$4.37K – 237
2023
Q3 		$4.37K Hold
124
– – ﹤0.01% 255
2023
Q2 		$4.71K Buy
+124
New +$4.94K ﹤0.01% 269

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marquette Asset Management's GMAB Position: Q4 2023 in Review

Marquette Asset Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 124 shares — an estimated $4.37K sold.

Marquette Asset Management first reported a position in GMAB in Q2 2023 and held it in 2 quarters. The position peaked at $4.71K in Q2 2023. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Marquette Asset Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Marquette Asset Management sold 124 Genmab shares in Q4 2023, an estimated $4.37K.
  • Marquette Asset Management first reported a position in Genmab in Q2 2023 and held it in 2 quarters.
  • Marquette Asset Management's Genmab position peaked at $4.71K in Q2 2023.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Marquette Asset Management's 13F filing for Q4 2023, filed 2 Feb 2024.